EGETIS THERAPEUTICS AB NPV financial statements, including revenue, expenses, profit, and loss

The total revenue of 0ABW for the last quarter is 9.40 M SEK, and it's 32.37% lower compared to the previous quarter. The net income of Q3 24 is -86.20 M SEK.